Zalba S - Search Results

1

Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling.

Parra-Guillen ZP, Sancho-Araiz A, Mayawala K, Zalba S, Garrido MJ, de Alwis D, Troconiz IF, Freshwater T. Parra-Guillen ZP, et al. Among authors: zalba s. Clin Pharmacol Ther. 2023 Sep;114(3):623-632. doi: 10.1002/cpt.2937. Epub 2023 Jun 2. Clin Pharmacol Ther. 2023. PMID: 37170933

2

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.

Saeed M, van Brakel M, Zalba S, Schooten E, Rens JA, Koning GA, Debets R, Ten Hagen TL. Saeed M, et al. Among authors: zalba s. Int J Nanomedicine. 2016 Mar 8;11:955-75. doi: 10.2147/IJN.S96123. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27022262 Free PMC article.

3

Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin.

Moreno D, Zalba S, Colom H, Trocóniz IF, Tros de Ilarduya C, Garrido MJ. Moreno D, et al. Among authors: zalba s. Eur J Pharm Sci. 2009 Jun 28;37(3-4):341-50. doi: 10.1016/j.ejps.2009.03.005. Epub 2009 Mar 24. Eur J Pharm Sci. 2009. PMID: 19491025

4

Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.

Moreno D, Zalba S, Navarro I, Tros de Ilarduya C, Garrido MJ. Moreno D, et al. Among authors: zalba s. Eur J Pharm Biopharm. 2010 Feb;74(2):265-74. doi: 10.1016/j.ejpb.2009.10.005. Epub 2009 Oct 31. Eur J Pharm Biopharm. 2010. PMID: 19883755

5

Efficient gene delivery by EGF-lipoplexes in vitro and in vivo.

Buñuales M, Düzgüneş N, Zalba S, Garrido MJ, de Ilarduya CT. Buñuales M, et al. Among authors: zalba s. Nanomedicine (Lond). 2011 Jan;6(1):89-98. doi: 10.2217/nnm.10.100. Nanomedicine (Lond). 2011. PMID: 21182421

6

Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo.

Zalba S, Navarro I, Trocóniz IF, Tros de Ilarduya C, Garrido MJ. Zalba S, et al. Eur J Pharm Biopharm. 2012 Jun;81(2):273-80. doi: 10.1016/j.ejpb.2012.02.007. Epub 2012 Feb 18. Eur J Pharm Biopharm. 2012. PMID: 22369879 Free article.

7

Efficient serum-resistant lipopolyplexes targeted to the folate receptor.

Urbiola K, García L, Zalba S, Garrido MJ, Tros de Ilarduya C. Urbiola K, et al. Among authors: zalba s. Eur J Pharm Biopharm. 2013 Apr;83(3):358-63. doi: 10.1016/j.ejpb.2012.10.012. Epub 2012 Nov 10. Eur J Pharm Biopharm. 2013. PMID: 23148988

8

Liposomes, a promising strategy for clinical application of platinum derivatives.

Zalba S, Garrido MJ. Zalba S, et al. Expert Opin Drug Deliv. 2013 Jun;10(6):829-44. doi: 10.1517/17425247.2013.778240. Epub 2013 Mar 8. Expert Opin Drug Deliv. 2013. PMID: 23470129 Review.

9

Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.

Zalba S, Contreras AM, Haeri A, Ten Hagen TL, Navarro I, Koning G, Garrido MJ. Zalba S, et al. J Control Release. 2015 Jul 28;210:26-38. doi: 10.1016/j.jconrel.2015.05.271. Epub 2015 May 19. J Control Release. 2015. PMID: 25998052 Free article.

10

EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model.

Zalba S, Contreras AM, Merino M, Navarro I, de Ilarduya CT, Trocóniz IF, Koning G, Garrido MJ. Zalba S, et al. Nanomedicine (Lond). 2016;11(5):465-77. doi: 10.2217/nnm.15.208. Epub 2016 Feb 19. Nanomedicine (Lond). 2016. PMID: 26892017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters